KALA BIO, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
KALA BIO, INC. (KALA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.40 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-19
- KALA BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 1.40K shares, a 99.24% decline year-over-year.
- KALA BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 760.22K shares, a 303.96% increase year-over-year.
- KALA BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 8.65M shares, a 2.65% decline year-over-year.
- KALA BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 184.12K shares, a 97.93% decline year-over-year.
- KALA BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 20.17M shares, a 128.53% increase from fiscal 2024.
- KALA BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 8.83M shares, a 35.95% increase from fiscal 2023.
- KALA BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 6.49M shares, a 311.97% increase from fiscal 2022.
- KALA BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.58M shares, a 586.71% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.40K shares 10-Q · filed 2026-08-19 | 380.81K shares 10-Q · filed 2026-08-19 | |||||
| 2026-03-31 | 760.22K shares 10-Q · filed 2026-05-15 | ||||||
| 2025-12-31 | 20.17M shares 10-K · filed 2026-04-15 | ||||||
| 2025-09-30 | 8.65M shares 10-Q · filed 2025-11-19 | 9.09M shares 10-Q · filed 2025-11-19 | |||||
| 2025-06-30 | 184.12K shares 10-Q · filed 2026-08-19 | 9.21M shares 10-Q · filed 2025-08-08 | 186.16K shares 10-Q · filed 2026-08-19 | 9.31M shares 10-Q · filed 2025-08-08 | |||
| 2025-03-31 | 188.19K shares 10-Q · filed 2026-05-15 | 9.41M shares 10-Q · filed 2025-05-14 | |||||
| 2024-12-31 | 8.83M shares 10-K · filed 2026-04-15 | ||||||
| 2024-09-30 | 8.88M shares 10-Q · filed 2025-11-19 | 8.70M shares 10-Q · filed 2025-11-19 | |||||
| 2024-06-30 | 8.91M shares 10-Q · filed 2025-08-08 | 8.61M shares 10-Q · filed 2025-08-08 | |||||
| 2024-03-31 | 8.31M shares 10-Q · filed 2025-05-14 | ||||||
| 2023-12-31 | 6.49M shares 10-K · filed 2025-03-31 | ||||||
| 2023-09-30 | 6.62M shares 10-Q · filed 2024-11-12 | 6.35M shares 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | 6.77M shares 10-Q · filed 2024-08-06 | 6.21M shares 10-Q · filed 2024-08-06 | |||||
| 2023-03-31 | 5.65M shares 10-Q · filed 2024-05-14 | ||||||
| 2022-12-31 | 1.58M shares 10-K · filed 2024-03-29 | ||||||
| 2022-09-30 | 226.05K shares 10-Q · filed 2023-11-13 | 257.87K shares 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | 265.94K shares 10-Q · filed 2023-08-04 | 273.77K shares 10-Q · filed 2023-08-04 | 13.31M shares 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | 281.60K shares 10-Q · filed 2023-05-09 | 14.09M shares 10-Q · filed 2022-05-16 | |||||
| 2021-12-31 | 229.48K shares 10-K · filed 2023-03-03 | 11.03M shares 10-K · filed 2022-03-29 | |||||
| 2021-09-30 | 232.56K shares 10-Q · filed 2022-11-08 | 232.52K shares 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | 11.54M shares 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | 11.73M shares 10-Q · filed 2022-05-16 | ||||||
| 2020-12-31 | 9.94M shares 10-K · filed 2022-03-29 | ||||||
| 2017-12-31 | 3.85M shares 10-K · filed 2018-04-02 | ||||||
| 2017-09-30 | 3.84M shares 10-Q · filed 2017-11-07 | ||||||
| 2017-06-30 | 19.64M shares 10-Q · filed 2017-08-31 | ||||||
| 2016-12-31 | 19.55M shares 10-K · filed 2018-04-02 | ||||||
| 2016-09-30 | 19.42M shares 10-Q · filed 2017-11-07 | ||||||
| 2016-06-30 | 19.40M shares 10-Q · filed 2017-08-31 | ||||||
| 2015-12-31 | 9.64M shares 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |